HPGC Renmintongtai Pharmaceutical Corp Working Capital to Net Assets Ratio

Latest as of March 2026: 88.8%

HPGC Renmintongtai Pharmaceutical Corp working capital to net assets ratio. HPGC Renmintongtai Pharmaceutical Corp (600829) has a Working Capital to Net Assets ratio of 88.8% as of March 2026. Working capital of CN¥2.72 Billion (current assets of CN¥6.87 Billion minus current liabilities of CN¥4.15 Billion) is measured against net assets of CN¥3.06 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check HPGC Renmintongtai Pharmaceutical Corp tangible net worth ratio to evaluate the tangible quality of the company's equity base.

WC/NA Ratio

88.8%
Working Capital / Net Assets

Working Capital

CN¥2.72 Billion
CNY

Current Assets

CN¥6.87 Billion
CNY

Current Liabilities

CN¥4.15 Billion
CNY

Working Capital to Net Assets Ratio of HPGC Renmintongtai Pharmaceutical Corp (1994–2025)

Working capital to net assets ratio of HPGC Renmintongtai Pharmaceutical Corp from 1994 to 2025. This chart shows how HPGC Renmintongtai Pharmaceutical Corp's Working Capital to Net Assets ratio has evolved across 32 annual periods from 1994 to 2025. As of March 2026, the ratio stands at 88.8%, reflecting working capital of CN¥2.72 Billion against net assets of CN¥3.06 Billion CNY. See HPGC Renmintongtai Pharmaceutical Corp defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

HPGC Renmintongtai Pharmaceutical Corp Working Capital to Net Assets Ratio by Year (1994–2025)

HPGC Renmintongtai Pharmaceutical Corp working capital to net assets ratio by year from 1994 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for HPGC Renmintongtai Pharmaceutical Corp from 1994 to 2025, covering 32 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see HPGC Renmintongtai Pharmaceutical Corp asset portfolio.

Year WC/NA Ratio Working Capital (CNY) Net Assets Current Assets Current Liabilities Change (pp)
2025 88.8% CN¥2.68 Billion CN¥3.01 Billion CN¥6.69 Billion CN¥4.01 Billion ▲ +0.2 pp
2024 88.6% CN¥2.55 Billion CN¥2.88 Billion CN¥6.69 Billion CN¥4.13 Billion ▲ +1.2 pp
2023 87.4% CN¥2.40 Billion CN¥2.75 Billion CN¥6.92 Billion CN¥4.52 Billion ▲ +1.5 pp
2022 85.9% CN¥2.12 Billion CN¥2.46 Billion CN¥6.55 Billion CN¥4.43 Billion ▲ +2.7 pp
2021 83.1% CN¥1.83 Billion CN¥2.20 Billion CN¥6.19 Billion CN¥4.36 Billion ▼ -0.8 pp
2020 84.0% CN¥1.67 Billion CN¥1.99 Billion CN¥5.54 Billion CN¥3.86 Billion ▲ +2.1 pp
2019 81.9% CN¥1.51 Billion CN¥1.85 Billion CN¥5.07 Billion CN¥3.56 Billion ▲ +3.6 pp
2018 78.3% CN¥1.24 Billion CN¥1.58 Billion CN¥3.92 Billion CN¥2.69 Billion ▲ +1.4 pp
2017 76.9% CN¥1.24 Billion CN¥1.61 Billion CN¥4.32 Billion CN¥3.08 Billion ▼ -1.2 pp
2016 78.1% CN¥1.29 Billion CN¥1.65 Billion CN¥4.26 Billion CN¥2.98 Billion ▲ +5.2 pp
2015 72.9% CN¥1.04 Billion CN¥1.42 Billion CN¥3.68 Billion CN¥2.65 Billion ▲ +29.1 pp
2014 43.7% CN¥941.39 Million CN¥2.15 Billion CN¥1.99 Billion CN¥1.05 Billion ▲ +2.4 pp
2013 41.3% CN¥932.95 Million CN¥2.26 Billion CN¥2.32 Billion CN¥1.39 Billion ▼ -2.0 pp
2012 43.4% CN¥1.00 Billion CN¥2.31 Billion CN¥2.68 Billion CN¥1.68 Billion ▲ +9.1 pp
2011 34.2% CN¥662.57 Million CN¥1.94 Billion CN¥2.50 Billion CN¥1.84 Billion ▲ +1.4 pp
2010 32.8% CN¥571.12 Million CN¥1.74 Billion CN¥2.09 Billion CN¥1.52 Billion ▼ -3.8 pp
2009 36.6% CN¥606.34 Million CN¥1.66 Billion CN¥1.72 Billion CN¥1.11 Billion ▼ -2.2 pp
2008 38.8% CN¥638.97 Million CN¥1.65 Billion CN¥1.88 Billion CN¥1.24 Billion ▲ +4.2 pp
2007 34.5% CN¥485.12 Million CN¥1.41 Billion CN¥1.73 Billion CN¥1.24 Billion ▲ +0.4 pp
2006 34.1% CN¥369.56 Million CN¥1.08 Billion CN¥1.40 Billion CN¥1.03 Billion ▼ -3.4 pp
2005 37.5% CN¥333.51 Million CN¥888.23 Million CN¥1.25 Billion CN¥916.05 Million ▲ +11.5 pp
2004 26.1% CN¥271.14 Million CN¥1.04 Billion CN¥965.71 Million CN¥694.57 Million ▲ +27.4 pp
2003 -1.4% CN¥-7.68 Million CN¥560.39 Million CN¥346.54 Million CN¥354.22 Million ▼ -12.1 pp
2002 10.7% CN¥56.56 Million CN¥526.17 Million CN¥381.29 Million CN¥324.73 Million ▲ +0.5 pp
2001 10.2% CN¥51.29 Million CN¥501.11 Million CN¥414.14 Million CN¥362.84 Million ▼ -22.2 pp
2000 32.5% CN¥151.42 Million CN¥466.36 Million CN¥543.96 Million CN¥392.54 Million ▲ +8.1 pp
1999 24.4% CN¥102.79 Million CN¥422.13 Million CN¥359.88 Million CN¥257.09 Million ▲ +6.8 pp
1998 17.5% CN¥75.41 Million CN¥430.69 Million CN¥308.64 Million CN¥233.23 Million ▼ -4.5 pp
1997 22.0% CN¥93.82 Million CN¥426.02 Million CN¥308.87 Million CN¥215.04 Million ▲ +12.8 pp
1996 9.2% CN¥38.18 Million CN¥413.92 Million CN¥233.75 Million CN¥195.57 Million ▼ -4.2 pp
1995 13.5% CN¥55.21 Million CN¥409.86 Million CN¥245.36 Million CN¥190.16 Million ▼ -16.4 pp
1994 29.9% CN¥121.46 Million CN¥406.37 Million CN¥243.62 Million CN¥122.16 Million —
pp = percentage points